Hansa Biopharma Hosts Virtual Event on Transplant Surgery and Im lifidase Phase 3 Results
Hansa Biopharma AB announced a virtual event featuring distinguished transplant surgeons Professor Robert Montgomery and Professor Matthew Cooper.
The event will provide insights into the medical journey of highly sensitized patients awaiting a kidney transplant and share perspectives on the clinical relevance of the topline results from the US Phase 3 ConfIdeS study.
- Date: Wednesday, 12 November 2025
- Time: 9:00 AM EST / 15:00 PM CET
No quote available in the text.
For more information, contact +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT.
Author's summary: Hansa Biopharma hosts a virtual event on transplant surgery.
More News
- Editorial: Movable bike barrier a good step for Richmond Bridge
- Tomago’s slow death exposes folly of ‘Made in Australia’ dream
- An Illinois wealth tax would be a legal disaster
- Ugly estate disputes are getting more common, but can be prevented
- Inquiring Photographer: Thoughts on Reduced Speed Limit for E-bikes and E-Scooters of 15 mph - Norwood News
- New landowner guides to energy development | Pembina Institute
- Employee consultation begins at Rio Tinto-led aluminium smelter over future operations